The Reversal Becomes a Trend
H1 2024 flagged a reversal of the take-rate» story that defined Adyen's first two public reports: net revenue was growing meaningfully slower than the processed volume generating it, the opposite of the flywheel that carried the IPO-era narrative. The FY2024 annual report - the company's first full audited year of financials since that half-year check-in - confirms it wasn't a one-half blip. Full-year take rate came in at 15.5 bps, down from 16.8 bps in FY2023 - a second consecutive annual decline, now backed by two full-year data points sitting inside the same audited filing rather than one half-year read. Processed volume grew 33% to €1,285.9 billion (from roughly €966.8 billion) while net revenue grew 23% to €1,996.1 million - volume still comfortably outrunning revenue, just as it did in H1.
Management's own framing hasn't changed either: "this decline is a natural outcome of our tiered pricing model, in which we embrace the land-and-expand strategy that fuels our growth." That's the same explanation offered at the half-year mark, and it's no more verifiable from what's filed now than it was then - the annual report still doesn't break out take rate by customer tier, by pillar, or by cohort (see Beyond the Usual). What is new this year: EBITDA margin reached 50%, up from 46% in FY2023 - a year ahead of management's own "above 50% in 2026" target - so the operating-leverage half of the 2018 thesis is arriving on schedule even as the take-rate half keeps moving the wrong way. Two years of the same directional take-rate move is no longer easy to wave off as noise.
The Prescription
What Adyen should keep pushing: full-stack acquiring, which climbed to 83% of processed volume in FY2024 (from 81% in FY2023) - still the highest-margin way Adyen touches a transaction, and still the cleanest structural counterweight to a declining take rate that this site has identified across three years of Adyen coverage. Every additional point of full-stack share raises the revenue ceiling on the exact volume that's currently diluting the blended take rate - a more durable answer than hoping mega-merchant mix normalizes on its own.
What it should stop doing: treating headcount as a lever to yank in response to market sentiment. The H1 2024 post flagged a sharp deceleration to just 37 net-new joiners in the first six months of 2024, down hard from the "two-year accelerated hiring phase" that fed 2023's margin scare. The full-year number tells a different story: 149 net new joiners for all of FY2024, meaning roughly 112 were added in the second half alone - a reacceleration that undoes most of H1's caution within the same year. Whipsawing from near-zero net hiring to a second-half surge inside a single fiscal year isn't disciplined long-term planning either; it reads like a company still calibrating headcount to whichever half just went well, rather than a steady multi-year plan that wouldn't need correcting twice in twelve months.
Key Financial Metrics
FY2024 vs. FY2023 - consolidated, audited annual financial statements
FX: EUR 1 = USD 1.0406 (December 31, 2024 close).
| Metric | FY2024 (EUR) | FY2024 (USD) | FY2023 (EUR) | YoY |
|---|---|---|---|---|
| Processed volume | €1,285.9Bn | ~$1,338.1Bn | ~€966.8Bn | ✅ +33% |
| Net Revenue | €1,996.1M | ~$2,077.4M | €1,626.1M | ✅ +22.8% |
| EBITDA | €992.3M | ~$1,032.6M | €743.0M | ✅ +33.5% |
| Operating Income (income before net finance income and income taxes) | €887.8M | ~$923.9M | €657.6M | ✅ +35.0% |
| Net Income | €925.2M | ~$962.9M | €698.3M | ✅ +32.5% |
| Free Cash Flow (FCF)» (EBITDA - CapEx - lease payments) | €859.8M | ~$894.9M | €639.5M | ✅ +34.5% |
| Total Cash and cash equivalents | €9,965.0M | ~$10,371.6M | €8,307.0M | ✅ +20.0% |
| Balance sheet metric | 31 Dec 2024 (EUR) | 31 Dec 2024 (USD) | 31 Dec 2023 (EUR) | Change |
|---|---|---|---|---|
| Total Assets | €11,425.3M | ~$11,888.4M | €9,568.4M | ✅ +19.4% |
| Total Equity | €4,231.5M | ~$4,403.5M | €3,150.9M | ✅ +34.3% |
| Total Liabilities | €7,193.8M | ~$7,485.0M | €6,417.5M | ➖ +12.1% |
| Payables to merchants and financial institutions | €6,684.7M | ~$6,955.5M | €5,953.6M | ➖ +12.3% |
Net revenue growth of 22.8% (Adyen rounds to 23%) sits at the low end of management's own "low-twenties to high-twenties" annual guidance range - not a miss, but the least room to spare inside that band since this site started tracking the guidance. EBITDA margin hit 50%, up from 46%, as operating expenses grew 18% against 22.8% net revenue growth - real, continued operating leverage (see The Prescription above on the headcount side of that story). Free cash flow conversion improved to 87% from 86% - still turning nearly all of EBITDA into real cash. Net income growth (+32.5%) trailed operating income growth (+35.0%) this year - the opposite of H1 2024's pattern because finance income, while still large at €349.8 million for the full year, grew more slowly than the underlying payments business - net finance income was €338.9 million for FY2024 against €285.0 million in FY2023, a smaller relative boost than the doubling seen in H1 2024's comparison, since higher-for-longer rates were already largely baked into the FY2023 base by full-year FY2024.
Take rate fell for the second year running while EBITDA margin cleared its 2026 target a year early - the two halves of Adyen's 2018 thesis are now moving in opposite directions on schedule.
Key Operational Metrics
- Take rate: 15.5 bps in FY2024, down from 16.8 bps in FY2023 - the second consecutive annual decline (see The Reversal Becomes a Trend above and Beyond the Usual below).
- Net revenue by region: EMEA €1,147.0M (+26% YoY, 57% of net revenue), North America €536.0M (+25% YoY, 27%), Asia-Pacific €206.7M (+13% YoY, 10%), Latin America €106.4M (~0% YoY, 5%) - EMEA was the fastest-growing region this year, a shift from H1 2024 when North America led; LATAM's flat reported growth reflects FX headwinds against real underlying momentum, per the filing.
- Full-stack acquiring: 83% of processed volume, up from 81% in FY2023 - the highest-margin way Adyen can process a transaction (see The Prescription above).
- Point-of-sale (POS) volume: €232.7 billion, 18% of total processed volume, up from 16% in FY2023 - continued growth in in-person payment demand.
- Platforms pillar: over 145,000 platform business customers served, up from 104,000 disclosed at H1 2024's midpoint.
- Customer Net Promoter Score (NPS): 66, a new company high.
- FTE» headcount: 4,345 at December 31, 2024, up from 4,196 a year earlier (+149 net new joiners, +3.5% YoY) - a full-year number that reveals H1's near-freeze was followed by a second-half hiring surge (see The Prescription above).
- Customer concentration: Adyen's top 10 merchants represented 12% of revenue in FY2024, down from 16% in FY2023, with no single customer above 10% of revenue in either year (see Beyond the Usual below).
- Not available this quarter: a per-pillar (Digital / Unified Commerce / Platforms) processed-volume split - disclosed in the H1 2024 shareholder letter but not carried into this annual report, which discusses the three pillars narratively without volume figures - and an authorization-rate figure, neither of which appears in the filed annual financial statements.
Beyond the Usual
Take rate's decline now has two full years behind it, and the disclosure gap hasn't closed
FY2024's 15.5 bps take rate, down from 16.8 bps in FY2023, is the same directional move flagged in the H1 2024 post's take-rate finding - except now it's backed by two consecutive full fiscal years inside one audited filing rather than a single half-year comparison. Management's explanation is unchanged: a tiered pricing model that charges the largest-volume merchants less, deliberately trading take rate for growth. That's a coherent strategy, but the annual report still doesn't disclose take rate by tier, by pillar, or by cohort, so there's still no way to verify from what's filed how much of the decline is deliberate pricing choice versus competitive fee pressure Adyen would rather frame as a strategy. Two years running is long enough that this deserves a third data point before assuming it's simply the cost of a working land-and-expand model.
Hiring went from near-freeze to a second-half surge inside the same fiscal year
Full-year net hiring of 149 FTEs conceals a lopsided year: just 37 net additions in H1 2024, meaning roughly 112 were added in H2. That's a sharper within-year swing than a steady headcount plan would produce, and it follows directly from the pattern already flagged in the H1 2024 post - hiring pace tracking market sentiment about the last earnings report rather than a stable multi-year plan. Worth watching whether FY2025's pace lands closer to a steady state or keeps swinging half to half.
The eBay warrant flagged as "about to expire" got exercised instead
Back in H1 2024, the second of eBay's four volume-linked warrant tranches - originally from the 2018 long-term merchant contract - sat as a €1.4 million derivative liability with roughly seven months left before its January 31, 2025 expiration. During 2024, the contract was extended to June 30, 2025, and the tranche 2 milestone was met: eBay exercised it, and Adyen issued 403,724 new shares at €240 per share. The gross equity value and related deferred tax were moved out of the warrant reserve into share premium and retained earnings. Tranches 3 and 4 remain unvested, but their exercise price was fixed at the same moment tranche 2 vested, so both were reclassified from a derivative liability into the warrant reserve as equity instruments - the reserve itself now carries just €1.6 million at historic cost, down from €25.6 million a year earlier. The dilution this 2018 contract could still cause has narrowed to two remaining, unvested tranches under a contract that now expires mid-2025 rather than the small residual liability this site expected to simply lapse.
A customer-concentration risk flagged in the FY2018 report has shrunk from 47% to 12% of revenue
The FY2018 annual report flagged that Adyen's top 10 customers accounted for 47% of total revenue, with two individual merchants each above 10% - a concentration risk this site's own Prescription section argued mid-market expansion should address. Six years later, the FY2024 filing discloses top 10 customers at just 12% of revenue (down from 16% in FY2023), with no single customer above 10% in either year. That's the direct, disclosed payoff of the diversification this site called for back in 2018 - a genuine structural de-risking of the revenue base, not a claim made in a shareholder letter without a number behind it.
The US deferred tax asset shrank for the first time since this site started tracking it
The US deferred tax asset tied to employee share-option exercises - first disclosed unrecognized at roughly €39 million in FY2018, then recognized and grown to €84.9 million by H1 2024 - closed FY2024 at €83.3 million, down from €88.5 million at the end of FY2023. The decline reflects €16.8 million of the tax losses carried forward being utilized during the year and recognized directly in equity rather than through profit or loss. The same asset is still deducted from regulatory capital under CRR/CRD IV regardless of its IFRS recognition (€85.9 million deducted at FY2024, down from €91.0 million at FY2023) - the prudential treatment and the IFRS judgment continue to tell two different stories about the same number, but for the first time since this site began tracking it, that number moved down instead of up.
Bank guarantees kept doubling, and inventory management got a genuine cleanup
Outstanding bank guarantees and letters of credit reached €138.4 million at December 31, 2024, up from €50.7 million a year earlier - continuing the pattern flagged at H1 2024 (€112.7 million at that point), consistent with new acquiring licenses obtained in India and Mexico. Separately, Adyen reversed €8.7 million of inventory write-offs taken during prior supply-chain disruptions after reassessing the net realizable value of overstocked point-of-sale terminals, while inventory purchases fell from €138.5 million to €78.7 million as the company "normalized inventory turnover and adopted a more streamlined purchasing approach" - a genuine operational cleanup of a pandemic-era overstock problem, not a criticism of anything currently mismanaged.
The Stichting Administratiekantoor Adyen (STAK) related-party account - which held a €16.6 million net receivable from employees at the end of FY2023 - was wound down entirely during 2024 following the introduction of the Fixed Salary shares plan, leaving no STAK-related balance at year-end. No contingent legal liabilities are disclosed, and the filing states plainly that there were no events after the reporting period affecting the FY2024 financial statements.
Stock Price: The Recovery Continued Into H2
Adyen's shares closed at €1,288.40 on December 30, 2022 (start of this post's two-year lookback window) and ended FY2024 at €1,437.00 on December 31, 2024 - up 11.5% over the full window, though that headline number flattens a genuinely volatile two years covered in detail in the H1 2024 post: the July 2023 peak (€1,689.80), the August 2023 39%-in-a-day crash, the October 2023 trough (€633.90), and the recovery to €1,113.20 by the end of June 2024. What's new since that post: shares kept climbing through H2 2024, closing the year at €1,437.00 - up 29.1% from the June 2024 close in six months, though still short of the €1,568 close this site's last post recorded for March 2024. No stock split occurred during this window or since; Adyen's only split (2-for-1) remains August 2021, so every price above is an actual nominal close, not a split-adjusted figure.
The H2 2024 recovery lines up with the operating story above: EBITDA margin clearing 50% a year early and net income growing faster than net revenue gave the market a profitability story to reward, even with take rate still declining. The stock's return to growth mode despite a second straight year of take-rate compression suggests the market is currently pricing the margin story more heavily than the take-rate one - worth remembering when reading Target Valuation Range below.
Target Valuation Range
~48.4x trailing P/E, ~35.5x EV/EBITDA. Bottom line: fully valued, leaning rich - both higher than H1 2024's ~42.2x and ~30.5x. Adyen is being priced for more than a business that already hit its 2026 margin target a year early; the market is also paying up for growth resuming after H1's dip, while a second straight year of take-rate decline still hasn't been fully explained by what's filed.
| Market cap → enterprise value | FY2024 (period-end) |
|---|---|
| Share price (period-end, Dec 31, 2024 close) | see Stock Price above |
| Shares outstanding | 31,485,187 |
| Market capitalization | ~€45.2 billion (~$47.1 billion) |
| Less: cash and equivalents | €9,965.0 million |
| Interest-bearing debt | none |
| Enterprise value | ~€35.3 billion (~$36.7 billion) |
| Peer-multiple sanity check | H1 2024 | FY2024 | Change |
|---|---|---|---|
| EPS (basic) | €26.38 (annualized) | €29.69 (full-year, audited) | ✅ up |
| P/E (basic) | ~42.2x | ~48.4x | ⚠️ up |
| P/E (diluted) | ~42.3x | ~48.6x | ⚠️ up |
| Book value per share | €115.14 | €134.41 | ✅ up |
| P/B | ~9.7x | ~10.7x | ⚠️ up |
| EV/Revenue | ~14.1x | ~17.7x | ⚠️ up |
| EV/EBITDA | ~30.5x | ~35.5x | ⚠️ up |
FY2024's P/E is a real full-year audited figure, not the annualized half-year estimate H1 2024 had to rely on. No peer-multiple comparison against another company is included here - no other global enterprise payments processor is currently covered on this site with a verified, downloaded annual filing to compare against. A full multi-year DCF also isn't built: this post's usable source documents span H1 2018, FY2018, H1 2024, and now FY2024, with a large gap between the early and recent periods that isn't a reliable base for modeling a continuous multi-year growth and margin trajectory.
What the market is pricing in (reverse-DCF logic, directional only): a higher multiple than six months ago is betting that the operating-leverage story (50% EBITDA margin, a year ahead of guidance) continues compounding even as take rate keeps sliding - essentially the same bet as H1 2024, taken with more conviction and at a higher price. The math only works if processed-volume growth (33% this year) keeps outrunning take-rate compression by enough to hold net revenue growth inside guidance every year through 2026, since there's no sign yet that take rate is close to stabilizing.
- Bear case: take rate keeps compressing for a third straight year while processed-volume growth decelerates from its current 33% pace (the same setup that preceded the 2023 selloff), pulling net revenue growth toward or below the bottom of guidance with a now-richer multiple to absorb the disappointment.
- Base case: net revenue growth holds inside the guided range through 2026, EBITDA margin stays comfortably above 50%, and today's higher multiple proves a fair price for a business converting 87% of EBITDA to free cash flow with a genuinely shrinking customer-concentration risk (see Beyond the Usual above).
- Bull case: full-stack acquiring expansion (83% of volume and rising) and new-market licenses in India and Mexico let Adyen capture more of the payment stack per transaction fast enough that take rate stabilizes even as new lower-margin volume comes online, validating the higher multiple the market is now paying.
Adyen's 2024 Annual Report and Consolidated Financial Statements (audited), for the year ended December 31, 2024, released March 7, 2025. Stock price history covers December 2022 through December 2024; the August 2023 selloff and November 2023 Investor Day guidance referenced above (via the H1 2024 post) were both public knowledge well before this report's release date and are cited only for context already available at the time.